In the current study, we sought to characterize intratumoral and peritumoral expression of HBsAg and its specific receptors NTCP and ASGPR in 115 HBsAg-positive HCC patients by tissue microarray and immunohistochemistry and further examined their correlation with the RFS of these patients. This evidence concerns the gene SLC10A1 and hepatocellular carcinoma.